CTRI/2019/07/020274尚未招募未知
Comparative efficacy of methotrexate, apremilast and their combination in psoriasis vulgaris.
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients of psoriasis vulgaris requiring systemic therapy. (Body surface area > 10% or
- •PASI score > 10 or non-responsive to topical therapy)
- •2. Patients above the age of 18 years.
- •3. Patients consenting for contraception required for methotrexate therapy.
排除标准
- •1. Patients suffering from any other significant systemic illness.
- •2. History of anti-psoriatic treatment in the last 2 months.
- •3. Pregnant or lactating women.
研究者
相似试验
已完成
不适用
APREMEPSa study: A comparative study between Apremilast and Methotrexate regarding their efficacy in psoriatic arthritisCTRI/2019/10/021723o sponsor31
尚未招募
不适用
An Observational Study To compare oral apremilast to oral methotrexate in psoriasis patients.CTRI/2019/02/017579DR H ANCHTIHA
尚未招募
3 期
Assessing the effectiveness of methotrexate and actinomycin D in the treatment of patients with C-section ectopic pregnancyIRCT20151020024625N16Iran University of Medical Sciences32
尚未招募
3 期
Assessing the effectiveness of Methotrexat versus Azathioprine on disease activity index in Lichen planopilaris patientsIRCT20191006045005N2Esfahan University of Medical Sciences32
已完成
3 期
Effect of oral methotrexate and oral prednisolone in Lichen planopilarisIRCT20190911044742N1Esfahan University of Medical Sciences28